Edward Rowe

The Importance of Hospital and Surgeon Volume as Major Determinants of Morbidity and Mortality After Radical Cystectomy for Bladder Cancer: A Systematic Review and Recommendations by the European Association of Urology Muscle-invasive and Metastatic Bladder Cancer Guideline Panel

Testosterone Therapy in Men with Androgen Deficiency Syndromes: An Endocrine Society Clinical Practice Guideline

European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines

False-positive screening results in the Finnish prostate cancer screening trial

Randomized Trial Comparing Open Radical Cystectomy and Robot-assisted Laparoscopic Radical Cystectomy: Oncologic Outcomes

Serum PSA and Percent Free PSA Value Changes after Antibiotic Treatment

EAU Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent—Update 2013

Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement

Robotic versus open radical cystectomy for bladder cancer in adults

Venous Thromboembolism and Peri-Operative Chemotherapy for Muscle-Invasive Bladder Cancer: A Population-based Study

Diagnostic Value of Systematic Biopsy Methods in the Investigation of Prostate Cancer: A Systematic Review

Incidental acute prostatic inflammation is associated with a lower percentage of free prostate‐specific antigen than other benign conditions of the prostate: a prospective screening study

Early Recurrence Patterns Following Totally Intracorporeal Robot-assisted Radical Cystectomy: Results from the EAU Robotic Urology Section (ERUS) Scientific Working Group

Prostate cancer detection in men with a ‘normal’ total prostate‐specific antigen (PSA) level using percentage free PSA: a prospective screening study

Prostate cancer detection rates in lateral versus medial cores when adopting a 12 core biopsy strategy in prostates larger than 40 CC

The British Association of Urological Surgeons radical cystectomy audit 2014/2015: An update on current practice, and an analysis of the effect of centre and surgeon case volume

Thromboembolic events with cisplatin-based neoadjuvant chemotherapy for transitional cell carcinoma of urinary bladder.

Robot‐assisted radical cystectomy with intracorporeal urinary diversion: impact on an established enhanced recovery protocol